Last update April 15, 2024
Compatible
We do not have alternatives for كوليستيرامين since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
كوليستيرامين is Colestyramine in Arabic.
Is written in other languages:كوليستيرامين is also known as
كوليستيرامين belongs to this group or family:
Main tradenames from several countries containing كوليستيرامين in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 0 | % |
Molecular weight | > 1.000.000 | daltons |
T½ | 0.1 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Cholestyramine is a bile acid binding resin with which it forms an insoluble complex that is excreted in the feces. It prevents the normal reabsorption of bile acids and forces the liver to produce more bile, thus reducing the body's cholesterol levels (especially LDL), since cholesterol is a major component of bile. Oral administration twice a day.
At the time of the last update, we found no published data on breastfeeding.
The intestinal absorption of the drug is null (AEMPS 2013, New Zealand Data Sheet 2010), so it cannot pass into breast milk, nor would it pass into the infant's plasma from ingested breast milk.
In addition, its high molecular weight makes it very unlikely to pass into breast milk in significant quantities.
Its prolonged use can cause plasma deficiency, due to lack of absorption, of fat-soluble vitamins (A, D, E, K), so it may be advisable to supplement to avoid deficiency of these vitamins in breast milk.
Several medical societies, experts and expert consensus consider safe the use of this medication during breastfeeding (Hale, LactMed, Lawrence 2016 p393, Serrano 2015, Briggs 2015, Heetun 2007, Mahadevan 2006).
It is advisable to follow a lipid-lowering diet and engage in regular physical activity daily, at least half an hour daily.
For considerations on the appropriateness of lipid-lowering treatment during breastfeeding see Maternal hyperlipidemia, hypercholesterolemia, hypertriglyceridemia.
See below the information of this related product: